The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

An Arkansas woman is sharing her story of becoming a new mom and beating the odds while fighting uterine cancer.

An Arkansas woman is sharing her story of becoming a new mom and beating the odds while fighting uterine cancer.

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

Lynch syndrome is a hereditary condition that sharply raises the risk of several types of cancer. Caused by inherited ...

June is uterine cancer awareness month, one of the few cancers with a rising death rate in the U.S and researchers are working<a class="excerpt-read-more" href=" More ...

Gaps in testing mean that many womb cancer patients with Lynch syndrome go undetected, leaving them at risk of developing ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...

This week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all ...